Global X China Biotech (USD) (9820)
Market Closed
17 Aug, 08:00
HKEX HKEX Primary $
9. 56
+0.07
+0.7376%
$
- Market Cap
- Div Yield
27,550 Volume
$ 9.49
Previous Close Want to track 9820 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
9820 closed today higher at $9.56, an increase of 0.7376% from yesterday's close, completing a monthly increase of 11.0982% or $0.96. Over the past 12 months, 9820 stock gained 9.1324%.
9820 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
9820 Chart
Global X China Biotech (USD) (9820) FAQ
What is the stock price today?
The current price is $9.56.
On which exchange is it traded?
Global X China Biotech (USD) is listed on HKEX.
What is its stock symbol?
The ticker symbol is 9820.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Global X China Biotech (USD) ever had a stock split?
No, there has never been a stock split.
Global X China Biotech (USD) Profile
| HKEX Exchange | Hong Kong Country |
The Global X China Biotech ETF is an exchange-traded fund designed to provide exposure to Chinese companies operating within the biotechnology sector. Its primary function is to track the performance of the Solactive China Biotech Index, which includes Chinese businesses involved in the development and commercialization of biotechnological products and services. This ETF allows investors to gain insight into a burgeoning market characterized by significant innovation and growth potential, as China's biotechnology industry benefits from increased government support, growing healthcare demands, and a shift towards advanced medical solutions. The Global X China Biotech ETF impacts sectors such as pharmaceuticals, healthcare, and bioengineering by concentrating on companies specialized in gene editing, cellular therapy, and novel drug development. In the financial market, it plays a crucial role for investors seeking diversified exposure to cutting-edge Chinese biotech firms without the need to pick individual stocks, thereby offering a streamlined approach to participating in a major segment of China's rapidly expanding healthcare landscape.
Contact Information
Address: -
Phone: +82 (0)23 774 2222
